首页>The Lancet infectious diseases>Serological response to three alternative series of hepatitis B revaccination Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial
Serological response to three alternative series of hepatitis B revaccination Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial
作者单位:Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Radboud Inst Hlth Sci, Nijmegen[1]Reg Publ Hlth Serv West Brabant, Dept Infect Dis, Breda, Netherlands[2]Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands[3]Maastricht Univ, Med Ctr, Care & Publ Hlth Res Inst CAPHRI, Dept Med Microbiol, Maastricht[4]Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands[5]